相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Altering the viscoelastic properties of mucus-grown Pseudomonas aeruginosa biofilms affects antibiotic susceptibility
Kaitlyn R. Rouillard et al.
BIOFILM (2023)
PHYSIOLOGY AND PATHOPHYSIOLOGY OF HUMAN AIRWAY MUCUS
David B. Hill et al.
PHYSIOLOGICAL REVIEWS (2022)
Delivery of oligonucleotide-based therapeutics: challenges and opportunities
Suzan M. Hammond et al.
EMBO MOLECULAR MEDICINE (2021)
Lipid Nanoparticles-From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement
Rumiana Tenchov et al.
ACS NANO (2021)
Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10 kb C-to-T splicing mutation
Yifat S. Oren et al.
JOURNAL OF CYSTIC FIBROSIS (2021)
Ivacaftor in People with Cystic Fibrosis and a 3849+10kb C→T or D1152H Residual Function Mutation
Eitan Kerem et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)
Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy
Kasia Dzierlega et al.
GENE THERAPY (2020)
Efficient Delivery of Antisense Oligonucleotides Using Bioreducible Lipid Nanoparticles In Vitro and In Vivo
Liu Yang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
CFTR modulator theratyping: Current status, gaps and future directions
John Paul Clancy et al.
JOURNAL OF CYSTIC FIBROSIS (2019)
Insights on animal models to investigate inhalation therapy: Relevance for biotherapeutics
A. Guillon et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Advances in therapy for spinal muscular atrophy: promises and challenges
Ewout J. N. Groen et al.
NATURE REVIEWS NEUROLOGY (2018)
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
E. Mercuri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Do Not
R. L. Juliano
NUCLEIC ACID THERAPEUTICS (2018)
Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH
David B. Hill et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
The US Food and Drug Administration's Experience with Ivacaftor in Cystic Fibrosis Establishing Efficacy Using In Vitro Data in Lieu of a Clinical Trial
Anthony G. Durmowicz et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2018)
Inhaled ENaC antisense oligonucleotide ameliorates cystic fibrosis-like lung disease in mice
Jeff R. Crosby et al.
JOURNAL OF CYSTIC FIBROSIS (2017)
The chemical evolution of oligonucleotide therapies of clinical utility
Anastasia Khvorova et al.
NATURE BIOTECHNOLOGY (2017)
Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators
Iwona M. Pranke et al.
SCIENTIFIC REPORTS (2017)
WS18.6 QR-010 penetrates the CF-like mucus barrier in vitro and in vivo
V. Brinks et al.
Journal of Cystic Fibrosis (2016)
Toward the modeling of mucus draining from human lung: role of airways deformation on air-mucus interaction
Benjamin Mauroy et al.
FRONTIERS IN PHYSIOLOGY (2015)
Local and systemic tolerability of a 2′O-methoxyethyl antisense oligonucleotide targeting interleukin-4 receptor-α delivery by inhalation in mouse and monkey
Robert A. Fey et al.
INHALATION TOXICOLOGY (2014)
Antisense oligonucleotides: modifications and clinical trials
Vivek K. Sharma et al.
MEDCHEMCOMM (2014)
Comparison of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Ciliary Beat Frequency Activation by the CFTR Modulators Genistein, VRT-532, and UCCF-152 in Primary Sinonasal Epithelial Cultures
Bryant T. Conger et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2013)
RNA therapeutics: beyond RNA interference and antisense oligonucleotides
Ryszard Kole et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
C. Frank Bennett et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
Yimin Hua et al.
GENES & DEVELOPMENT (2010)
Anti-inflammatory activity of inhaled IL-4 receptor-α antisense oligonucleotide in mice
James G. Karras et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Development of a sensitive and specific in situ hybridization technique for the cellular localization of antisense oligodeoxynucleotide drugs in tissue sections
Nancy Goebl et al.
TOXICOLOGIC PATHOLOGY (2007)
Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice
M Mall et al.
NATURE MEDICINE (2004)
分享论文
